Search

Your search keyword '"Tonini, Gian Paolo"' showing total 204 results
Start Over Author "Tonini, Gian Paolo" Database Unpaywall
204 results on '"Tonini, Gian Paolo"'

1. List of Contributors

Author

Aminzadeh-Gohari, Sepideh, primary, Aveic, Sanja, additional, Aye, J., additional, Ayers, Duncan, additional, Beierle, E.A., additional, Croteau, Nicole J., additional, Dyer, Michael A., additional, Feichtinger, René Günther, additional, Grumati, Paolo, additional, Gupta, Ravi Kant, additional, Gustafson, William Clay, additional, Hung, Jung-Tung, additional, Ikegaki, Naohiko, additional, Inomistova, Mariia, additional, Irwin, Meredith S., additional, Khranovska, Natalia, additional, Kofler, Barbara, additional, Kudva, Anupa, additional, Kumar, Prerna, additional, Kumar, Rakesh, additional, La Quaglia, Michael P., additional, Matthay, Katherine K., additional, Modak, Shakeel, additional, Morgenstern, Daniel A., additional, Nguyen, Rosa, additional, Ray, Swapan K., additional, Ribatti, Domenico, additional, Saltsman, James A., additional, Schor, Nina F., additional, Shimada, Hiroyuki, additional, Skachkova, Oksana, additional, Stafman, L.L., additional, Tonini, Gian Paolo, additional, and Yu, Alice L., additional

Published
2019
Full Text
View/download PDF

3. Data from Role of CXCL13-CXCR5 Crosstalk Between Malignant Neuroblastoma Cells and Schwannian Stromal Cells in Neuroblastic Tumors

Author

Del Grosso, Federica, primary, Coco, Simona, primary, Scaruffi, Paola, primary, Stigliani, Sara, primary, Valdora, Francesca, primary, Benelli, Roberto, primary, Salvi, Sandra, primary, Boccardo, Simona, primary, Truini, Mauro, primary, Croce, Michela, primary, Ferrini, Silvano, primary, Longo, Luca, primary, and Tonini, Gian Paolo, primary

Published
2023
Full Text
View/download PDF

4. Data from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Table 1 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Table 2 from Role of CXCL13-CXCR5 Crosstalk Between Malignant Neuroblastoma Cells and Schwannian Stromal Cells in Neuroblastic Tumors

Author

Del Grosso, Federica, primary, Coco, Simona, primary, Scaruffi, Paola, primary, Stigliani, Sara, primary, Valdora, Francesca, primary, Benelli, Roberto, primary, Salvi, Sandra, primary, Boccardo, Simona, primary, Truini, Mauro, primary, Croce, Michela, primary, Ferrini, Silvano, primary, Longo, Luca, primary, and Tonini, Gian Paolo, primary

Published
2023
Full Text
View/download PDF

7. Data from Role of CXCL13-CXCR5 Crosstalk Between Malignant Neuroblastoma Cells and Schwannian Stromal Cells in Neuroblastic Tumors

Author

Del Grosso, Federica, primary, Coco, Simona, primary, Scaruffi, Paola, primary, Stigliani, Sara, primary, Valdora, Francesca, primary, Benelli, Roberto, primary, Salvi, Sandra, primary, Boccardo, Simona, primary, Truini, Mauro, primary, Croce, Michela, primary, Ferrini, Silvano, primary, Longo, Luca, primary, and Tonini, Gian Paolo, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table 2 from Role of CXCL13-CXCR5 Crosstalk Between Malignant Neuroblastoma Cells and Schwannian Stromal Cells in Neuroblastic Tumors

Author

Del Grosso, Federica, primary, Coco, Simona, primary, Scaruffi, Paola, primary, Stigliani, Sara, primary, Valdora, Francesca, primary, Benelli, Roberto, primary, Salvi, Sandra, primary, Boccardo, Simona, primary, Truini, Mauro, primary, Croce, Michela, primary, Ferrini, Silvano, primary, Longo, Luca, primary, and Tonini, Gian Paolo, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Table 1 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table 1 from Role of CXCL13-CXCR5 Crosstalk Between Malignant Neuroblastoma Cells and Schwannian Stromal Cells in Neuroblastic Tumors

Author

Del Grosso, Federica, primary, Coco, Simona, primary, Scaruffi, Paola, primary, Stigliani, Sara, primary, Valdora, Francesca, primary, Benelli, Roberto, primary, Salvi, Sandra, primary, Boccardo, Simona, primary, Truini, Mauro, primary, Croce, Michela, primary, Ferrini, Silvano, primary, Longo, Luca, primary, and Tonini, Gian Paolo, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure S4 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figure S4 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figure S2 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure S1 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure S2 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure S1 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Table 1 from Role of CXCL13-CXCR5 Crosstalk Between Malignant Neuroblastoma Cells and Schwannian Stromal Cells in Neuroblastic Tumors

Author

Del Grosso, Federica, primary, Coco, Simona, primary, Scaruffi, Paola, primary, Stigliani, Sara, primary, Valdora, Francesca, primary, Benelli, Roberto, primary, Salvi, Sandra, primary, Boccardo, Simona, primary, Truini, Mauro, primary, Croce, Michela, primary, Ferrini, Silvano, primary, Longo, Luca, primary, and Tonini, Gian Paolo, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Materials and Methods from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Materials and Methods from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure S3 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure S3 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy

Author

Sidarovich, Viktoryia, primary, De Mariano, Marilena, primary, Aveic, Sanja, primary, Pancher, Michael, primary, Adami, Valentina, primary, Gatto, Pamela, primary, Pizzini, Silvia, primary, Pasini, Luigi, primary, Croce, Michela, primary, Parodi, Federica, primary, Cimmino, Flora, primary, Avitabile, Marianna, primary, Emionite, Laura, primary, Cilli, Michele, primary, Ferrini, Silvano, primary, Pagano, Aldo, primary, Capasso, Mario, primary, Quattrone, Alessandro, primary, Tonini, Gian Paolo, primary, and Longo, Luca, primary

Published
2023
Full Text
View/download PDF

22. Supplementary Table 2 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Table 3 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Table 4 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

32. Legends to Supplementaries from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Data 2 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Data 2 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

40. Legends to Supplementaries from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Author

Oberthuer, André, primary, Juraeva, Dilafruz, primary, Hero, Barbara, primary, Volland, Ruth, primary, Sterz, Carolina, primary, Schmidt, Rene, primary, Faldum, Andreas, primary, Kahlert, Yvonne, primary, Engesser, Anne, primary, Asgharzadeh, Shahab, primary, Seeger, Robert, primary, Ohira, Miki, primary, Nakagawara, Akira, primary, Scaruffi, Paola, primary, Tonini, Gian Paolo, primary, Janoueix-Lerosey, Isabelle, primary, Delattre, Olivier, primary, Schleiermacher, Gudrun, primary, Vandesompele, Jo, primary, Speleman, Frank, primary, Noguera, Rosa, primary, Piqueras, Marta, primary, Bénard, Jean, primary, Valent, Alexander, primary, Avigad, Smadar, primary, Yaniv, Isaac, primary, Grundy, Richard G., primary, Ortmann, Monika, primary, Shao, Chunxuan, primary, Schwab, Manfred, primary, Eils, Roland, primary, Simon, Thorsten, primary, Theissen, Jessica, primary, Berthold, Frank, primary, Westermann, Frank, primary, Brors, Benedikt, primary, and Fischer, Matthias, primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure Legend from Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Author

Barbieri, Eveline, primary, De Preter, Katleen, primary, Capasso, Mario, primary, Chen, Zaowen, primary, Hsu, Danielle M., primary, Tonini, Gian Paolo, primary, Lefever, Steve, primary, Hicks, John, primary, Versteeg, Rogier, primary, Pession, Andrea, primary, Speleman, Frank, primary, Kim, Eugene S., primary, and Shohet, Jason M., primary

Published
2023
Full Text
View/download PDF

42. Data from Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients

Author

Passoni, Lorena, primary, Longo, Luca, primary, Collini, Paola, primary, Coluccia, Addolorata Maria Luce, primary, Bozzi, Fabio, primary, Podda, Marta, primary, Gregorio, Andrea, primary, Gambini, Claudio, primary, Garaventa, Alberto, primary, Pistoia, Vito, primary, Del Grosso, Federica, primary, Tonini, Gian Paolo, primary, Cheng, Mangeng, primary, Gambacorti-Passerini, Carlo, primary, Anichini, Andrea, primary, Fossati-Bellani, Franca, primary, Di Nicola, Massimo, primary, and Luksch, Roberto, primary

Published
2023
Full Text
View/download PDF

43. Supplementary Methods from Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Author

Barbieri, Eveline, primary, De Preter, Katleen, primary, Capasso, Mario, primary, Chen, Zaowen, primary, Hsu, Danielle M., primary, Tonini, Gian Paolo, primary, Lefever, Steve, primary, Hicks, John, primary, Versteeg, Rogier, primary, Pession, Andrea, primary, Speleman, Frank, primary, Kim, Eugene S., primary, and Shohet, Jason M., primary

Published
2023
Full Text
View/download PDF

44. Supplementary Table 3 from Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Author

Barbieri, Eveline, primary, De Preter, Katleen, primary, Capasso, Mario, primary, Chen, Zaowen, primary, Hsu, Danielle M., primary, Tonini, Gian Paolo, primary, Lefever, Steve, primary, Hicks, John, primary, Versteeg, Rogier, primary, Pession, Andrea, primary, Speleman, Frank, primary, Kim, Eugene S., primary, and Shohet, Jason M., primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure 1 from Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Author

Barbieri, Eveline, primary, De Preter, Katleen, primary, Capasso, Mario, primary, Chen, Zaowen, primary, Hsu, Danielle M., primary, Tonini, Gian Paolo, primary, Lefever, Steve, primary, Hicks, John, primary, Versteeg, Rogier, primary, Pession, Andrea, primary, Speleman, Frank, primary, Kim, Eugene S., primary, and Shohet, Jason M., primary

Published
2023
Full Text
View/download PDF

46. Supplementary Figure 1 from Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Author

Barbieri, Eveline, primary, De Preter, Katleen, primary, Capasso, Mario, primary, Chen, Zaowen, primary, Hsu, Danielle M., primary, Tonini, Gian Paolo, primary, Lefever, Steve, primary, Hicks, John, primary, Versteeg, Rogier, primary, Pession, Andrea, primary, Speleman, Frank, primary, Kim, Eugene S., primary, and Shohet, Jason M., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Figure 2 from Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Author

Barbieri, Eveline, primary, De Preter, Katleen, primary, Capasso, Mario, primary, Chen, Zaowen, primary, Hsu, Danielle M., primary, Tonini, Gian Paolo, primary, Lefever, Steve, primary, Hicks, John, primary, Versteeg, Rogier, primary, Pession, Andrea, primary, Speleman, Frank, primary, Kim, Eugene S., primary, and Shohet, Jason M., primary

Published
2023
Full Text
View/download PDF

48. Supplementary Table 3 from Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Author

Barbieri, Eveline, primary, De Preter, Katleen, primary, Capasso, Mario, primary, Chen, Zaowen, primary, Hsu, Danielle M., primary, Tonini, Gian Paolo, primary, Lefever, Steve, primary, Hicks, John, primary, Versteeg, Rogier, primary, Pession, Andrea, primary, Speleman, Frank, primary, Kim, Eugene S., primary, and Shohet, Jason M., primary

Published
2023
Full Text
View/download PDF

49. Supplementary Figure 4 from Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Author

Barbieri, Eveline, primary, De Preter, Katleen, primary, Capasso, Mario, primary, Chen, Zaowen, primary, Hsu, Danielle M., primary, Tonini, Gian Paolo, primary, Lefever, Steve, primary, Hicks, John, primary, Versteeg, Rogier, primary, Pession, Andrea, primary, Speleman, Frank, primary, Kim, Eugene S., primary, and Shohet, Jason M., primary

Published
2023
Full Text
View/download PDF

50. Supplementary Figure 2 from Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Author

Barbieri, Eveline, primary, De Preter, Katleen, primary, Capasso, Mario, primary, Chen, Zaowen, primary, Hsu, Danielle M., primary, Tonini, Gian Paolo, primary, Lefever, Steve, primary, Hicks, John, primary, Versteeg, Rogier, primary, Pession, Andrea, primary, Speleman, Frank, primary, Kim, Eugene S., primary, and Shohet, Jason M., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results